-
公开(公告)号：WO2022033781A1
公开(公告)日：2022-02-17
申请号：PCT/EP2021/069115
申请日：2021-07-09
Applicant: FRIESLANDCAMPINA NEDERLAND B.V.
IPC: A23C19/09 , A23J3/22 , A23J3/28 , A23L29/256 , A23L33/16 , A23L33/165 , A23L33/19 , A23L33/21 , A23L33/28
Abstract: Process for the preparation of a fibrous product comprising protein and having a moisture content of at least 65% by weight based on total weight of fibrous product by first preparing a homogenous mixture of protein material comprising cheese, a moisture binder material, a calcium-complex forming agent, a hydrocolloid which precipitates with metal cations and water at a temperature in the range of 70 to 90 °C under high shear with the pH of the homogenous mixture being in the range of 6.4 to 7.5. The homogenous mixture has a water content of at least 75% by weight based on total weight of the homogenous mixture, whilst total protein content is in the range of 5 to 20% by weight based on total weight of the homogenous mixture. A solution of a metal cation with a valency of at least 2 is subsequently added in order to form the fibrous product. This fibrous product is then isolated and cooled. The fibrous product thus obtained is particularly suitable for use in preparing meat substitute products.
-
2.发明申请PREPARAÇÃO DE PRODUTOS DE CEREAIS APROPRIADOS PARA DOENTES CELÍACOS ATRAVÉS DA FORMAÇÃO DE ESTRUTURAS SUPRAMOLECULARES DE PROTEÍNAS E QUITOSANA 审中-公开制备谷物产品适合乳糜泻患者THROUGH超分子蛋白质结构的形成和壳聚糖
公开(公告)号：WO2018011714A1
公开(公告)日：2018-01-18
申请号：PCT/IB2017/054181
申请日：2017-07-11
Applicant: UNIVERSIDADE DE TRÁS-OS-MONTES E ALTO DOURO
Inventor： FERREIRA MILHEIRO NUNES, Fernando Hermínio , IGREJAS, Gilberto , SILVA FERREIRA RIBEIRO, José Miguel
Abstract: A presente invenção é referente a um processo de destoxificação da farinha de trigo ( Triticum spp.) e glúten através da formação de estruturas supramoleculares com a quitosana. A invenção refere-se também à respetiva farinha e glúten destoxificados em que são obtidos valores de redução de epitopos tóxicos para os doentes celíacos de 65 e 88% quando comparados com a farinha e glúten não modificados ou originais, respetivamente. Adicionalmente diz ainda respeito à utilização do processo de destoxificação noutros cereais e respetivos produtos, nomeadamente em outras gramíneas (Poaceae), subfamília Pooideae, principalmente das espécies da tribo Triticeae como a cevada ( Hordeum spp.), o centeio ( Secale spp.), o triticale (x Triticosecale ) e da tribo Aveneae como a aveia ( Avena spp.), bem como os seus produtos germinados.
Abstract translation: 本发明涉及制备本发明的方法。 与通过用壳聚糖形成超分子结构的小麦面粉（Triticum spp。）和谷氨酰胺的解毒过程有关。 本发明还涉及制备式（I）化合物的方法， 相应的面粉和GL＆uacute; 10解毒其中s＆HAND获得的值减少MAKE-HANDS，表位T＆oacute; xicos为CEL＆iacute患者，钢65和88％相比，面粉和GL＆uacute，10 N'HAND改性或 原件，分别。 另外它说尊重和加重; 使用＆ccedil;＆HAND所述的排毒＆ccedil过程;＆HAND其它谷物及其制品，特别是其它克＆iacute; NEAS（禾本科），亚科＆iacute; LIA早熟禾亚科，特别是ESP＆eacute;所述小麦族的CIES如大麦（大麦 的属物种），黑麦（黑麦属的属），小黑麦（X 小黑麦属的）和Aveneae部落如燕麦（燕麦 spp。），以及他们发芽的产品。
-
公开(公告)号：WO2022229111A1
公开(公告)日：2022-11-03
申请号：PCT/EP2022/060918
申请日：2022-04-25
Applicant: GELITA AG
Inventor： MCKIBBIN, Mindi , MONTGOMERY, Michelle A. , WALLER, Ginger , YEZDIMIR, Eric
Abstract: Disclosed is an edible, discontinuous gummy delivery system comprising peptide particles with an average particle size from 5 to 500 µm and an average molecular weight from 1,000 to 10,000 Da dispersed in an elastic matrix, wherein the peptide particles are undissolved or no more than partially dissolved in the elastic matrix, and wherein the peptide particles are present in an amount from 8 to 45% of a total mass of the delivery system. Methods of preparing the gummy delivery systems are also disclosed.
-
公开(公告)号：WO2020038685A1
公开(公告)日：2020-02-27
申请号：PCT/EP2019/070349
申请日：2019-07-29
Applicant: GELITA AG
Inventor： GRÜBER, Anne-Sophie , HAHN, Martin , LANG, Elvira
IPC: A23L7/117 , A23L29/281 , A23L33/18 , A23L33/28
Abstract: Die vorliegende Erfindung betrifft einen Proteinriegel, der aus einer formbaren Masse gebildet ist, die Proteine und/oder Proteinhydr olysate enthält. Die formbare Masse enthält ein Kollagenhydrolysat mit einem mittleren Molekulargewicht von bis zu 1.700 Da als ein Proteinhydrolysat.
-
公开(公告)号：WO2017191838A1
公开(公告)日：2017-11-09
申请号：PCT/JP2017/017210
申请日：2017-05-01
Applicant: 有限会社梅田事務所 , 株式会社ピーソリューション
IPC: C07F9/10 , A23K20/158 , A23L33/28 , A61K8/60 , A61K8/68 , A61K9/08 , A61K9/107 , A61K31/683 , A61K35/57 , A61K47/26 , A61P25/00 , A61P25/18 , A61P25/28 , A61P29/00 , A61P43/00 , A61Q19/00 , C11B11/00
CPC classification number: A23K20/158 , A23L33/28 , A61K8/60 , A61K8/68 , A61K9/08 , A61K9/107 , A61K31/683 , A61K35/57 , A61K47/26 , A61Q19/00 , C07F9/10 , C11B11/00 , Y02W30/74
Abstract: 本発明は、安全・安定なプラズマローゲンとその製剤及び認知症未病状態の判定方法を提供するものであり、より詳しくは、本発明は、鶏の生体組織の特定の部位と臓器から抽出分別され、ＤＨＡを含むω－３高度不飽和脂肪酸（ωー３ＨＵＦＡ）誘導体を含有する飼料で飼養された鶏の生体組織に当該ω－３ＨＵＦＡ誘導体が移行した生体組織特異的な構成比を有するプラズマローゲン含有複合脂質等から成る、ω－３ＨＵＦＡ結合型のプラズマローゲン等を有効成分とする認知症の緩和、改善、予防用のサプリメント又は食品としての加工品、並びに神経変性疾患及び／又は精神疾患治療用製剤、及び認知症発症前の成人（健常者）を被験者として、該被験者の認知症未病状態を判定する方法から構成される。
Abstract translation:
本发明是提供一种制剂和痴呆非病理状态的安全和稳定的缩醛磷脂和确定方法，并且更具体地，本发明中，鸡体组织 从特定网站和器官，ω-3高度不饱和脂肪酸（超过3个HUFAs欧米加），ω-3 HUFAs衍生物已进给的饮食含有DHA含衍生物已经迁移鸡的生物体组织的生物组织特异性提取分离 构成比例由含有缩醛磷脂复合脂等具有，ω-3 HUFAs痴呆的减轻，其包括缩醛磷脂等，改善工件作为补充剂或食品用于预防作为活性成分的结合形式，以及神经变性 疾病和/或精神病症治疗制剂，和痴呆发病前的成年人（健康受试者），其为主体，并确定所述受试者的痴呆非病理状态的方法。
-
Patent Agency Ranking
公开(公告)号：WO2022112592A1
公开(公告)日：2022-06-02
申请号：PCT/EP2021/083524
申请日：2021-11-30
Applicant: DSM IP ASSETS B.V.
Inventor： BUTZ, Jochen, Alexander , LINDEMANN, Thomas , TSEKOU, Christos , URBAN, Kai , SCHAEFER, Christian
IPC: A23L33/105 , A23K10/32 , A23K20/174 , A23L33/15 , A23L33/155 , A23L33/28
Abstract: The present invention is directed to beadlets with a self-heating temperature ≥ 120°C comprising gelatin, lignosulfonate, a low amount of antioxidant, and Vitamin A or a derivative thereof and optionally Vitamin D or a derivative thereof, as well as to a container with a volume ranging from 450 l to 3000 l comprising such beadlets. The present invention is further directed to a process for the manufacture of such beadlets, their use as additive to feed and premixes and feed additives, premixes and feed comprising such beadlets.
-
公开(公告)号：WO2021121699A1
公开(公告)日：2021-06-24
申请号：PCT/EP2020/077243
申请日：2020-09-29
Applicant: GELITA AG
Inventor： GUILLEAUME, Birgit , HAHN, Martin , STECK, Birgit
IPC: A23C11/10 , A23L29/281 , A23L33/125 , A23L33/18 , A23L33/28 , A23L33/00 , A23L29/284 , A23L33/40
Abstract: Die vorliegende Erfindung betrifft ein Milchersatzprodukt, umfassend 1 bis 4 Gew.% pflanzliches Fett; 2 bis 5 Gew.% Kollagenhydrolysat; 3 bis 6 Gew.% Kohlenhydrat; und 80 bis 94 Gew.% Wasser, wobei das pflanzliche Fett als Öl-in-Wasser-Emulsion vorliegt, und wobei die Menge an Kollagenhydrolysat zwischen 70 und 75 Gew.% der Menge an Kohlenhydrat beträgt. Die Erfindung betrifft ferner ein Verfahren zur Herstellung dieses Milchersatz- produktes, umfassend die Schritte: - Mischen von pflanzlichem Fett, Kollagenhydrolysat, Kohlenhydrat, Wasser und optional weiteren Komponenten; - Erhitzen der Mischung auf eine Temperatur von 60 bis 90 °C, bevorzugt von 75 bis 85 °C; und - Homogenisieren der Mischung, bevorzugt mittels Hochdruckhomogeni- sation bei einem Druck von 150 bis 350 bar.
-
公开(公告)号：WO2020169612A1
公开(公告)日：2020-08-27
申请号：PCT/EP2020/054253
申请日：2020-02-18
Applicant: TESSENDERLO GROUP NV
Inventor： WU, Yingying
IPC: A23L33/28 , A23L2/52 , A23G3/44 , A23L29/281
Abstract: The present invention relates to a composition comprising collagen hydrolysate and amorphous gelatin, said composition being non-agglomerated. The invention is particularly useful in the production of various food products, more particularly healthy food products in need of texture. Also the invention is useful in the production of pet food, cosmetic or pharmaceutical products.
-
公开(公告)号：WO2018027083A1
公开(公告)日：2018-02-08
申请号：PCT/US2017/045388
申请日：2017-08-03
Applicant: SEATTLE GUMMY COMPANY
Inventor： WAN, Feng
IPC: A23L33/165 , A23L33/18 , A23L33/28
CPC classification number: A23L33/165 , A23L2/66 , A23L33/18 , A23L33/28
Abstract: The nutraceutical composition includes a gelling component in a sufficient amount to provide a cohesive gelled product, and a peptide chelated mineral composition. In one embodiment, the peptide chelated mineral composition includes a collagen chelated mineral composition.
Abstract translation: 营养制品组合物包含足够量的胶凝组分以提供粘性凝胶化产物和肽螯合矿物质组合物。 在一个实施方案中，肽螯合的矿物质组合物包含胶原螯合的矿物质组合物。
-
公开(公告)号：WO2023027859A1
公开(公告)日：2023-03-02
申请号：PCT/US2022/038620
申请日：2022-07-28
Applicant: ABBOTT LABORATORIES
IPC: A23L33/175 , A23L33/28
Abstract: A nutritional composition comprises HMB, arginine, glutamine, and an exosome-enriched product comprising intact bovine milk-derived exosomes. A method for improving wound healing in a subject comprises administering beta-hydroxy-beta-methylbutyrate (HMB), arginine, glutamine, and an exosome-enriched product comprising intact bovine milk-derived exosomes to the subject in need thereof. A method for improving wound healing in a subject comprises administering a nutritional composition comprising HMB, arginine, glutamine, and an exosome-enriched product comprising intact bovine milk-derived exosomes.
-
-
-
-
-
-
-
-
-
Search Results
20
records
(took 0.011 seconds)
